Previous article Next article

The UK Competition Authority fines 3 pharmaceutical companies for taking part in an illegal arrangement in relation to the supply of life-saving medicine (Aspen / Tiofarma / Amilco)

CMA levies fines of £2.3m and secures £8m for NHS in pharma probe* The CMA has formally concluded that 3 pharmaceutical companies took part in an illegal arrangement in relation to the supply of life-saving medicine. The investigation by the

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

  • United Kingdom’s Competition Authority - CMA (London)

Quotation

UK Competition Authority, The UK Competition Authority fines 3 pharmaceutical companies for taking part in an illegal arrangement in relation to the supply of life-saving medicine (Aspen / Tiofarma / Amilco), 9 July 2020, e-Competitions Preview, Art. N° 95940

Visites 36

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues